#UNESCO commemorates World #ScienceDay today emphasizing the importance of building trust in science. OncoProTools also believes that science has a primary role in our daily lives and we join today's celebration by raising awareness of our research.
https://t.co/VKozPjIdss
#OncoProTools research was showcased at the Helmholtz Immunology & Inflammation Conference 2024! Our #MSCA fellow Hugo Boutier presented groundbreaking work on UniCAR T-cell therapy, advancing cancer treatment safety & efficacy.
👉 https://t.co/pjllyMUJcj
#Immunotherapy#H2021
News from Rome! Our #MSCA PhD fellows, Hugo Boutier from @HZDR_Dresden and Hector Caballero from @cellply showcased their latest research findings at this year’s edition of the #ESCGT24 conference in Rome.
#CancerResearch#OncoProTools#H2021 @MSCActions
News from #OncoProTools! Our team member Claudia Arndt (@HZDR_Dresden), successfully co-organized the Annual Meeting of the Tumor Immunology Study Group (@dgfi_org) alongside Jörg Wischhusen (@Uniklinikum_Wue), where Hugo Boutier (#MSCA fellow at #HZDR) showcased his research.💡
🎓🌍 News from Cambridge! Héctor Caballero, #MSCA fellow & PhD researcher at @cellply, joined the prestigious #FS2S workshop at @Cambridge_Uni, connecting with peers & keynote lecturers to explore translating research into impactful solutions for society!
#H2021#OncoProTools
📝 EFMC-YSN Reviewer Academy 📝
Powered by Chemistry Europe
The academy aims to teach best practices in peer review , especially for early-career researchers.
▶️ Online course
▶️ 1h workshop
▶️ Reviewing assignment(s)
📆 Next workshop on 28/10!
🔗 https://t.co/Io4YjUdPXy
Are you planning to pursue a PhD? Join a supportive environment, contribute to challenging and relevant projects, and advance your academic career.
#BeCNB
We have several opportunities for you! 👩🔬👨🔬🧑💻👩💻
Check our website for details: https://t.co/m5VRSjmGzs
@DPE_CSIC
#OncoProTools drives cancer research innovation through #MSCA training. At our annual meeting in Madrid, our young researchers shared progress, received feedback, & explored further collaborations. A huge thanks to @CNB_CSIC hosts & all participants!
#CancerResearch#H2021
⏳ It's the final countdown!
Our CEO will speak at the #WCC2024 on September 17-18, engaging in lively discussions focusing on equitable cancer treatment, innovative therapy policies, AMR, smoking cessation, and early detection.
Full programme 🔗https://t.co/0B7Tyjk4EG
Our team member, Thales do Valle Moreira, #MSCA doctoral fellow at @uni_mainz, presented his research at the seminar of the Brazil-Germany Program ProBrAl, organized by Prof. Louis Pergaud Sandjo at the Dept. of Chemistry of the @UFSC.
#H2021#collaboration#Protease#Erasmus
Our #MSCA fellow, Hugo Boutier - @HZDR_Dresden presented his research at #ECI2024!
UniCAR T-cell Potency – A Matter of Affinity?: a recently published study, exploring innovative approaches in engineering UniCAR T-cells for cancer treatment 👉 https://t.co/pjllyMUJcj
@H2021
📢 Exciting #JobOpportunity! 🎓Do you hold an MSc Degree in #environmentalsciences, chemistry, biology, or related fields? You still have 2 weeks to apply for this #PhDposition at @UFZ_de in Leipzig, Germany.
Vacancy 👉 https://t.co/XUr4K7BFpN
Apply 👉 https://t.co/KNogo4nhjd
📚 A preclinical evaluation of 68Ga- and 177Lu-labeled monomeric and dimeric #FAP inhibitors, revealing promising results for cancer diagnosis & treatment that could revolutionize #theranostics. Co-authored by @Adrianna Bilińska (@inselgruppe@unibern)
https://t.co/xWaKgvc9ej
#NewAlert! This study aims to understand how the affinity between the extracellular antibody-binding domain of the #UniCAR to the peptide epitope of a Target Module (TM) influences the functionality of UniCAR T-cells. By Hugo Boutier, et al. @HZDR_Dresden
https://t.co/OvvdJA01v1
14 June is #WorldBloodDonorDay! 🩸 Blood donations play a crucial role in #cancerresearch. For instance, we use healthy blood to isolate T-cells, produce CAR T-cells, and run further assays in the lab.
If you healthy and 18+, don't think it twice!
👉https://t.co/ksrsFX1E37